DAIVONEX
Manufacturer Details
WIN-MEDICARE
Compositions:
Calcipotriol 0.005%w/w capsules,
Calcipotriol 0.005%w/v SCALP SOLUTION,
|
Strength
|
Rate
|
Packing Style
|
|
0.005%w/w
|
350.00
|
15g capsule
|
|
0.005%w/w
|
691.50
|
25g capsules
|
|
0.005w/v
|
1068.00
|
30ml SCALP SOLUTION
|
List of Related Indications:
List Of Drugs:
- Calcipotriol - Dermatological
Indication Type Description:
Drug Interaction:
Calcium ,Vit D ,Salicylic acid
Indication:
New drugs approved For Marketing by Drug Controller General of India(DCGI )
during the period January 1988 to November 2014
(Ref- IDMA Annual Publication 2015)
Name of Drug Indication Date of Approval
Calcipotriol Gel 0.005% 03-10-2009
Addl.Dosage Form
For the treatment of moderate plaque psoriasis in adults
Adverse Reaction:
Transcient irritation, Dermmatitis, pruritus, aggravation of psoriasis, photosensitivity, Photosensitivity, Pigmentation changes, Hypercalaemia( excessive use)
Contra-Indications:
Severe extensive pustular psoriasis. Disorders of calcium metabolism. Not for ophthalmic use
Special Precautions- Pregnancy, lactatation. Avoid face, scalp, skin fold contact. No occulisive dressings. Excessive or prolonged use.
Monitor serum calcium, renal functions. Sun light exposure. Erythrodermic exfoliative psoriasis, photosensitivity. Pigmentation changes. Hypercalcaemia (excessive use)
Dosages/ Overdosage Etc:
For the treatment of moderate plaque psoriasis in adults
Apply to affected area once or twice daily for upto 4 to 6 weeks
